Mariner Wealth Advisors (NYC)’s Teva Pharmaceuticals TEVA Stock Holding History

Mariner Wealth Advisors (NYC)’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$139K	Buy	+2,231	New	+$130K	0.07%	82

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Mariner Wealth Advisors (NYC)'s TEVA Position: Q1 2015 in Review

Mariner Wealth Advisors (NYC) opened a new position in Teva Pharmaceuticals (TEVA) in Q1 2015: 2,231 shares worth $139K. The stake represents 0.07% of the portfolio and ranks #82 among its holdings.

822 funds tracked by Wall St. Rank hold TEVA as of Q1 2015.

Mariner Wealth Advisors (NYC) held 2,231 shares of Teva Pharmaceuticals worth $139K as of Q1 2015.
Teva Pharmaceuticals was a new Mariner Wealth Advisors (NYC) position in Q1 2015.
Teva Pharmaceuticals made up 0.07% of Mariner Wealth Advisors (NYC)'s portfolio in Q1 2015, its #82 holding.
822 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2015.

Based on Mariner Wealth Advisors (NYC)'s 13F filing for Q1 2015, filed 14 May 2015.